These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 21466419

  • 1. The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study.
    Imran M, Davison AS, Howse M, Williams P, Kemp GJ, Roberts NB.
    Clin Chem Lab Med; 2011 Jun; 49(6):1005-9. PubMed ID: 21466419
    [Abstract] [Full Text] [Related]

  • 2. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G, Mateş A, Gluhovschi C, Golea O, Gădălean F, Somai M, Ene I, Petrica L, Velciov S.
    Rom J Intern Med; 2014 Jun; 52(1):30-8. PubMed ID: 25000676
    [Abstract] [Full Text] [Related]

  • 3. Higher serum potassium level associated with late stage chronic kidney disease.
    Hsieh MF, Wu IW, Lee CC, Wang SY, Wu MS.
    Chang Gung Med J; 2011 Jun; 34(4):418-25. PubMed ID: 21880197
    [Abstract] [Full Text] [Related]

  • 4. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.
    Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R.
    Clin J Am Soc Nephrol; 2010 May; 5(5):762-9. PubMed ID: 20203167
    [Abstract] [Full Text] [Related]

  • 5. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B, Meuthen I.
    Dtsch Med Wochenschr; 1986 Feb 28; 111(9):329-32. PubMed ID: 3948731
    [Abstract] [Full Text] [Related]

  • 6. Investigation of outpatients referred to a chemical pathologist with potential pseudohyperkalaemia.
    Kapoor AK, Ravi A, Twomey PJ.
    J Clin Pathol; 2009 Oct 28; 62(10):920-3. PubMed ID: 19783721
    [Abstract] [Full Text] [Related]

  • 7. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 Oct 28; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 8. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.
    Eur J Prev Cardiol; 2014 Mar 28; 21(3):299-309. PubMed ID: 24191305
    [Abstract] [Full Text] [Related]

  • 9. [Must we always treat hyperkalaemia?].
    Basile C, Manobianca G, Bruno A, Tamma F.
    G Ital Nefrol; 2013 Mar 28; 30(1):. PubMed ID: 23832444
    [Abstract] [Full Text] [Related]

  • 10. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 28; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 11. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
    Koren-Michowitz M, Avni B, Michowitz Y, Moravski G, Efrati S, Golik A.
    Pharmacoepidemiol Drug Saf; 2004 May 28; 13(5):299-302. PubMed ID: 15133781
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S, Khan A, Vincent A, Lau K.
    Am J Med Sci; 2008 Oct 28; 336(4):330-5. PubMed ID: 18854676
    [Abstract] [Full Text] [Related]

  • 13. Predictors of hyperkalemia and death in patients with cardiac and renal disease.
    Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S.
    Am J Cardiol; 2012 May 15; 109(10):1510-3. PubMed ID: 22342847
    [Abstract] [Full Text] [Related]

  • 14. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ.
    Kaohsiung J Med Sci; 2012 Sep 15; 28(9):477-83. PubMed ID: 22974666
    [Abstract] [Full Text] [Related]

  • 15. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL, Deore R, El-Agnaf M.
    Int J Lab Hematol; 2010 Feb 15; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [Abstract] [Full Text] [Related]

  • 16. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
    Frimodt-Møller M, Høj Nielsen A, Strandgaard S, Kamper AL.
    Nephrol Dial Transplant; 2010 Mar 15; 25(3):842-7. PubMed ID: 19903661
    [Abstract] [Full Text] [Related]

  • 17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Mar 15; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 18. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
    McCullough PA, Beaver TM, Bennett-Guerrero E, Emmett M, Fonarow GC, Goyal A, Herzog CA, Kosiborod M, Palmer BF.
    Rev Cardiovasc Med; 2014 Mar 15; 15(1):11-23. PubMed ID: 24762462
    [Abstract] [Full Text] [Related]

  • 19. Pneumatic tube system transport and false hyperkalemia related to leukocytosis: a retrospective analysis.
    Grzych G, Roland E, Lezier D, Beauvais D, Maboudou P, Lippi G.
    Ann Biol Clin (Paris); 2019 Jun 01; 77(3):281-286. PubMed ID: 31115339
    [Abstract] [Full Text] [Related]

  • 20. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients.
    Phakdeekitcharoen B, Leelasa-nguan P.
    Am J Kidney Dis; 2004 Oct 01; 44(4):738-46. PubMed ID: 15384026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.